Key result
The recombinant virus rTH-98-D3-COE-HA induced specific immune responses in mice, including neutralizing antibody titers of 1:8 against PEDV and 1:16 against TGEV.
Why the study?
Transmissible gastroenteritis virus causes huge economic losses in the global pig industry, motivating the study of viral proteins and infectious clones.
The study successfully constructed a reverse genetic system for TGEV and demonstrated that ORF3 plays a critical role in inducing the host immune response, providing a foundation for recombinant viral multi-valent vaccines.
Introduction: Transmissible gastroenteritis virus (TGEV), as the causative agent of TGE, causes huge economic losses in the pig industry worldwide. Methods: In this study, we successfully constructed a reverse genetic system for the TGEV TH-98 strain and rescued the recombinant virus rTH-98-Δ3-COE-HA based on this system. Results: The results showed that ORF3 is a non-structural protein and does not exist in mature virions. Therefore, rTH-98-Δ3-COE-HA induced inflammatory cytokine expression in IPEC-J2 cells, but the expression levels were significantly lower than those triggered by TH-98 and rTH-98, indicating that TGEV ORF3 may play a critical role in inducing the host immune response. To detect whether the exogenous protein expressed in the rTH-98-Δ3-COE-HA has immunogenicity, the results showed that the levels of antibodies were significantly increased in mice. rTH-98-Δ3-COE-HA can induce a specific immune response in the host body against its expressed exogenous proteins. Discussion and conclusion: Our study provides important clues for revealing the role of ORF3 in virus replication and pathogenesis, laying a theoretical and material foundation for the construction of recombinant viral multi-valent vaccines.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied Transmissible gastroenteritis virus (TGEV) infection (n=60). rTH-98-D3-COE-HA vs. rTH-98, TH-98, or PBS was evaluated. The recombinant virus rTH-98-D3-COE-HA induced specific immune responses in mice, including neutralizing antibody titers of 1:8 against PEDV and 1:16 against TGEV.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: